CRISPR Therapeutics Payables and Accrued Expenses (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

60.81 +6.08 (+11.11%) USD | NASDAQ | Jan 22, 16:00

60.79 -0.02 (-0.03%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for CRSP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial